Investor Relations
Investor Relations Contact:
LHA
Anne Marie Fields
212-838-3777
afields@lhai.com
or
Bruce Voss
310-691-7100
bvoss@lhai.com

Media Contact
Rooney & Associates
Terry Rooney
212-223-0689
trooney@rooneyco.com
or
Marion Janic
212-223-4017
mjanic@rooneyco.com

OPKO Receives FDA Orphan Drug Status for its New Oligonucleotide to Treat Genetic Neurological Disorder more »

OPKO Health's GeneDx to have Significant Presence at ACMG 2017 more »

OPKO Health to Participate in the Barclays Global Healthcare Conference more »

OPKO Receives EU Orphan Drug Status for its New Oligonucleotide to Treat Genetic Neurological Disorder¬† more »

Email Alert Subscription

Unsubscribe from Emails

In order to ensure the privacy of our users, your email address must be verified in order to be removed from these lists. After filling out the form below, you will be sent a link to your email address that will remove you from our email lists. * Required fields

 
 
 
 
 
 


 
This helps OPKO Health, Inc. prevent automated submissions.

Email  Sign up for email alerts